Stay updated on Losmapimod in COVID: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.

Latest updates to the Losmapimod in COVID: Safety & Efficacy Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page's Locations list was updated to add new sites across multiple states and countries, and several previously listed locations were removed.SummaryDifference1%

- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe page footer now shows Revision: v3.3.2, replacing v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.1, a minor metadata change. No core content, study details, or outcomes were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check58 days agoChange DetectedRemoved the administrative banner about government funding lapse and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check72 days agoChange DetectedNo additions or deletions were detected between screenshots. The page content and layout appear unchanged, including the LOSVID study details.SummaryDifference0.4%

- Check101 days agoChange DetectedUpdate reflects a new version (v3.2.0) and a government-operating-status notice, replacing the previous v3.1.0 and guiding users to official status pages.SummaryDifference3%

Stay in the know with updates to Losmapimod in COVID: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.